Df Dent & CO Inc Bio Techne Corp Transaction History

Df Dent & CO Inc

$7.32 Billion
Q4 2024

A detailed history of Df Dent & CO Inc transactions in Bio Techne Corp stock. As of the latest transaction made, Df Dent & CO Inc holds 3,201,397 shares of TECH stock, worth $192 Million. This represents 3.15% of its overall portfolio holdings.

Number of Shares

3,201,397

Previous 3,298,695 2.95%

Holding current value

$192 Million

Previous $264 Million 12.52%

% of portfolio

3.15%

Previous 3.46%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$66.37 - $78.17 $6.46 Million - $7.61 Million	-97,298 Reduced 2.95%	3,201,397 $231 Million
Q3 2024 Nov 14, 2024	SELL	$70.96 - $82.35 $5.37 Million - $6.23 Million	-75,671 Reduced 2.24%	3,298,695 $264 Million
Q2 2024 Aug 14, 2024	SELL	$62.12 - $84.15 $1.41 Million - $1.9 Million	-22,636 Reduced 0.67%	3,374,366 $242 Million
Q1 2024 May 15, 2024	BUY	$65.98 - $77.09 $10.3 Million - $12 Million	155,830 Added 4.81%	3,397,002 $239 Million
Q4 2023 Feb 14, 2024	SELL	$52.83 - $78.22 $1.82 Million - $2.69 Million	-34,445 Reduced 1.05%	3,241,172 $250 Million
Q2 2023 Aug 14, 2023	BUY	$73.76 - $85.98 $242 Million - $282 Million	3,275,617 New	3,275,617 $267 Million
Q1 2023 May 15, 2023	BUY	$71.62 - $86.62 $22.2 Million - $26.8 Million	309,812 Added 11.74%	2,949,044 $219 Million
Q4 2022 Feb 15, 2023	BUY	$80.67 - $352.29 $159 Million - $693 Million	1,967,884 Added 293.12%	2,639,232 $219 Million
Q3 2022 Nov 14, 2022	SELL	$282.54 - $391.85 $3.58 Million - $4.97 Million	-12,678 Reduced 1.85%	671,348 $191 Million
Q2 2022 Aug 15, 2022	SELL	$322.67 - $449.65 $793,122 - $1.11 Million	-2,458 Reduced 0.36%	684,026 $237 Million
Q1 2022 May 16, 2022	BUY	$353.85 - $487.79 $1.79 Million - $2.47 Million	5,068 Added 0.74%	686,484 $297 Million
Q4 2021 Feb 14, 2022	SELL	$456.15 - $525.06 $38.5 Million - $44.3 Million	-84,464 Reduced 11.03%	681,416 $353 Million
Q3 2021 Nov 15, 2021	BUY	$444.87 - $538.88 $98,316 - $119,092	221 Added 0.03%	765,880 $371 Million
Q2 2021 Aug 16, 2021	SELL	$387.35 - $450.26 $39.8 Million - $46.3 Million	-102,743 Reduced 11.83%	765,659 $345 Million
Q1 2021 May 17, 2021	SELL	$314.62 - $411.0 $18.1 Million - $23.6 Million	-57,421 Reduced 6.2%	868,402 $332 Million
Q4 2020 Feb 16, 2021	BUY	$246.9 - $321.87 $6.51 Million - $8.49 Million	26,386 Added 2.93%	925,823 $294 Million
Q3 2020 Nov 16, 2020	BUY	$232.22 - $282.96 $11.1 Million - $13.6 Million	48,008 Added 5.64%	899,437 $223 Million
Q2 2020 Aug 14, 2020	BUY	$185.43 - $279.56 $10.9 Million - $16.4 Million	58,818 Added 7.42%	851,429 $225 Million
Q1 2020 May 15, 2020	BUY	$161.17 - $221.51 $6.55 Million - $9 Million	40,629 Added 5.4%	792,611 $150 Million
Q4 2019 Feb 14, 2020	SELL	$189.68 - $222.09 $416,726 - $487,931	-2,197 Reduced 0.29%	751,982 $165 Million
Q3 2019 Nov 14, 2019	BUY	$183.56 - $216.72 $28 Million - $33.1 Million	152,683 Added 25.38%	754,179 $148 Million
Q2 2019 Aug 15, 2019	BUY	$188.72 - $215.43 $480,292 - $548,269	2,545 Added 0.42%	601,496 $125 Million
Q1 2019 May 15, 2019	BUY	$136.09 - $200.44 $11.7 Million - $17.2 Million	85,671 Added 16.69%	598,951 $119 Million
Q4 2018 Feb 14, 2019	BUY	$132.75 - $203.8 $245,189 - $376,418	1,847 Added 0.36%	513,280 $74.3 Million
Q3 2018 Nov 15, 2018	SELL	$147.44 - $204.11 $83,893 - $116,138	-569 Reduced 0.11%	511,433 $104 Million
Q2 2018 Aug 15, 2018	SELL	$144.9 - $165.58 $90,707 - $103,653	-626 Reduced 0.12%	512,002 $75.8 Million
Q1 2018 May 15, 2018	BUY	$131.46 - $151.04 $15.9 Million - $18.3 Million	121,264 Added 30.98%	512,628 $77.4 Million
Q4 2017 Feb 15, 2018	SELL	$121.17 - $134.75 $528,664 - $587,914	-4,363 Reduced 1.1%	391,364 $50.7 Million
Q3 2017 Nov 15, 2017	BUY	$113.59 - $123.78 $45 Million - $49 Million	395,727	395,727 $47.8 Million

Others Institutions Holding TECH

# of Institutions

617

Shares Held

156M

Call Options Held

161K

Put Options Held

12.7K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.36B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Df Dent & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Df Dent & CO Inc with notifications on news.

Account